Your session is about to expire
← Back to Search
Biopsy Decision-Making for Kidney Tumors (GRADE-SRM Trial)
GRADE-SRM Trial Summary
This trial looks at whether biopsying small kidney tumors helps doctors make decisions about treatment, and also compares genomic information from biopsied tissue to information from surgery.
GRADE-SRM Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowGRADE-SRM Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.GRADE-SRM Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have a transplanted kidney.You had a biopsy of a small kidney mass in the past.I am willing to have a blood test for cancer DNA.I am willing and able to give informed consent.I am between 18 and 95 years old.My kidney tumor is 7 cm or smaller, as confirmed by UNC.My cancer has spread beyond its original location.I agree to provide additional biopsy samples for research.I agree to let my surgical samples be used for research.
- Group 1: Biopsy
- Group 2: No Biopsy
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is enrollment still open for participants in this research?
"Affirmative, according to the information on clinicaltrials.gov this ongoing medical trial was published on October 30th 2018 and has recently been updated (March 22nd 2022). 130 patients are needed for participation at one site."
Who qualifies to partake in this medical experiment?
"The study is actively searching for 130 individuals aged 18 to 95 who have been diagnosed with kidney neoplasms. To be eligible, applicants must also meet the following prerequisites: be evaluated at either UNC Urology or UNC Cancer Hospital and possess a small renal mass ≤7 cm as per cross-sectional radiologic studies; demonstrate willingness to complete patient-reported outcome questionnaires; provide permission for their surgical specimens to be used in research projects."
Is the age of entry for this trial restricted to those over 50 years old?
"As stated by the requirements, potential patients must be between 18 and 95 years of age to join this clinical trial."
What is the capacity of this research endeavor?
"Affirmative. According to the clinicaltrials.gov entry, this clinical trial began searching for candidates on October 30th 2018 and is still ongoing as of March 22nd 202022. The primary objective requires 130 individuals from one medical centre."
Share this study with friends
Copy Link
Messenger